Recherche avancée
Instruments
Nom | Mnemo | Place boursière | Volume moyen | Cours | Type | |
---|---|---|---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Japan Exchange +8 Autres | 3 469 807 | 4 192 JPY | Action | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Deutsche Boerse AG | 340 | 24,69 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0RN3 | London S.E. | 0 | 37,59 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Börse Stuttgart | - | 24,35 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | BOERSE MUENCHEN | 112 | 24,77 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKPHF | OTC Markets | 2 037 | 26,86 USD | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Wiener Boerse | - | 24,86 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Fukuoka Stock Exchange | 0 | 4 080 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Sapporo S.E. | 0 | 4 300 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK | Nyse +5 Autres | 1 258 872 | 13,36 USD | Action | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK N | Mexican S.E. | 4 851 | 240,5 MXN | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Deutsche Boerse AG | - | 12,1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Börse Stuttgart | - | 12,1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | BOERSE MUENCHEN | - | 12,3 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0A87 | London S.E. | 843 | 13,07 USD | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAKP34 | Sao Paulo | 413 | 69,86 BRL | Action | |
TAKEDA MACHINERY CO., LTD. | 6150 | Japan Exchange | 7 113 | 3 340 JPY | Action | |
TAKEDA IP HOLDINGS CO.,LTD. | 7875 | Japan Exchange | 8 160 | 852 JPY | Action | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDB | BOERSE MUENCHEN | - | 76,13 % | Obligation | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Börse Stuttgart | - | 91,82 % | Obligation | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDB | Börse Stuttgart | - | 76,21 % | Obligation | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Börse Stuttgart | - | 96,85 % | Obligation | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | LCDB | Singapore S.E. | - | - % | Obligation |
Profils Sociétés (6)
Takeda Pharmaceutical Company Limited est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques destinés essentiellement au traitement des maladies métaboliques et cardiovasculaires, des cancers et des troubl ...
Takeda iP Holdings Co Ltd, anciennement Takeda Printing Co Ltd, est principalement active dans le secteur de l'imprimerie. L'entreprise opère dans deux secteurs d'activité. Le secteur de l'impression comprend deux activités. L'activité d'impression est en ...
Affymax, Inc. est une société biopharmaceutique. Le produit de la société, OMONTYS (peginesatide), est destiné au traitement de l'anémie due à une maladie rénale chronique chez les patients adultes sous dialyse. OMONTYS est un agent synthétique de stimula ...
TAKEDA MACHINERY CO., LTD. est une société basée au Japon qui se consacre principalement à la fabrication et à la vente de machines de traitement de l'acier profilé et de machines à scie circulaire pour le traitement des cadres en acier, des matériaux en ...
Ligand Pharmaceuticals Incorporated est une société biopharmaceutique qui favorise le progrès scientifique en soutenant le développement clinique de médicaments. Pour ce faire, la société fournit des financements, accorde des licences sur ses technologies ...
DRI Healthcare Trust est une société canadienne dont l'activité consiste à fournir des financements pour faire progresser l'innovation dans le secteur des sciences de la vie. La société est impliquée dans la monétisation des redevances pharmaceutiques et ...
Insiders
M. Norimasa Takeda est chef comptable et contrôleur d'entreprise chez Takeda Pharmaceutical Co., Ltd.
Actuellement, Norimasa Sato occupe le poste de directeur financier et directeur général senior de Welcia Holdings Co., Ltd. et d'auditeur de Welcia Kaigo Service Co., Ltd. M. Sato est également membre du conseil d'administration de Welcia Yakkyoku Co., Ltd. Dans sa carrière antérieure, il a occupé le poste d'auditeur d'entreprise chez Ouen Kazoku Co., Ltd.
Actuellement, Norimasa Kitazawa est président et directeur représentatif de Pigeon Corp.
Actuellement, Chikashi Takeda occupe le poste de directeur financier chez Olympus Corp. Dans le passé, il a occupé le poste de Senior Executive Officer & Head-Finance chez Astellas Pharma, Inc.
Actuellement, Kazunori Takeda occupe le poste de vice-président exécutif et président du commerce chez Rakuten, Inc. M. Takeda est également membre du conseil d'administration de Gurunavi, Inc, de Rakuten General Insurance Co., Ltd, de Fusion Communications Corp et de Rakuten Vissel Kobe, Inc. Il est titulaire d'un MBA de la Harvard Business School.
Kazuhiko Takeda est membre du conseil d'administration de Sony (China) Co., Ltd. et directeur général de Sony Corp.
Norimasa Maida formerly worked at Toyo Seikan Group Holdings Ltd., as Director & Managing Executive Officer from 2015 to 2016 and Toyo Kohan Co., Ltd., as Executive Officer & GM-Chemical Products Planning from 2011 to 2016.
Norimasa Shinya is currently working as a Senior Analyst at Mizuho Securities Co., Ltd.
(Broker).
Norimasa Tamura has a current job as a Non-Executive Director at The Chugoku Electric Power Co., Inc.
Norimasa Matsuyama is a Member of The American Institute of Certified Public Accountants, and has previously worked as a Director at Renova, Inc. (Japan) and as a Principal at Kumagai Gumi Co., Ltd.
He obtained an undergraduate degree from Sophia University.
Norimasa Kishimoto has a current job as the Director & Manager-Chubu Sales at KITAKEI CO., LTD.
Norimasa Yamamizu is currently working as the Director, Executive Officer & GM-Foodstuffs at Shinyei Kaisha.
Norimasa Tanabe is currently a Partner at Ant Capital Partners Co., Ltd.
since 2009.
He previously worked as a Director at Kagayaku Cosmetics, Inc.
Norimasa Yoshida is an Independent Outside Director at Benefit Japan Co., Ltd.
since 2016.
He previously held positions as Chairman at Senshu Ikeda Holdings, Inc. and The Senshu Ikeda Bank Ltd., and as President at Senshu Bank Ltd.
Norimasa Tsunemi has a current job as the Director, Head-Accounting & Finance at Ensuiko Sugar Refining Co., Ltd.
Norimasa Sakata has worked as an Auditor at Mitani Sangyo Co., Ltd.
since 2016.
Norimasa Nosaka has a current job as Co-Managing Director at BBS Motorsport GmbH.
Norimasa Goto is currently holding multiple positions as Vice Chairman at NIDEC (Dalian) Ltd., Nidec (Dongguan) Corp., and Nidec Vietnam Corp.
He is also currently serving as Chairman at Nidec (Hong Kong) Co., Ltd.
In the past, he worked as a Director at NIDEC Corp.
Mr. Norimasa Ogawa is a Research Analyst at Daiwa Securities Capital Markets Co. Ltd.
Norimasa Komatsu is currently the President & Representative Director at Genesis Technology, Inc. since 1997.
Prior to this, he worked at Kobe Steel, Ltd.
as a Principal from 1974 to 1998.
Norimasa Fujii currently works at Fuji Foods, Inc. as the Head-Kanagawa Plant.
Norimasa Iida currently works at ONO SOKKI Co., Ltd., as Independent Outside Director from 2019.
Norimasa Takeshima held the position of President & Representative Director at Daido Sittipol Co. Ltd.
and Executive Officer at Daido Kogyo Co., Ltd.
Norimasa Kuroda is currently the Chairman of Shouohkai Foundation and a Non-Executive Director at JTB Corp.
He previously held positions as Chairman at Mizuho Trust & Banking Co., Ltd., Independent Outside Director at Tokyo Tatemono Co., Ltd., Outside Director at Sompo Japan Insurance, Inc., and Deputy President at Mizuho Bank Ltd.
Norimasa Kamura worked as a Manager of Personnel & General Affairs at Daiichi Sankyo Co., Ltd.
Toru Takeda is currently working as an Auditor at Seikagaku Corp.
He started this position in 2016.
Previously, he worked as an Auditor at Mizuho Trust & Banking Co., Ltd.
Osamu Takeda currently works at Kobundo Co., Ltd., as Senior Managing Director.
Yoshinobu Takeda is currently the President & Representative Director at Data Applications Co., Ltd.
since 2015.
He is also an Outside Director at Cyberlinks Co., Ltd.
Mr. Takeda previously worked as a Director at Holon Technology KK and Kagoshima Data Applications KK.
Yasuhumi Takeda is associated with Milbon Co., Ltd.
since 1981.
He currently holds the position of Director & General Manager-Development, which he started in 2014.
Tsuneharu Takeda is an Outside Director at Mandarin Oriental Tokyo Co., Ltd.
since 2013.
He previously served as an Independent Outside Director at Kureha Corp.
and as an Outside Director at KCJ Group, Inc.
Keiji Takeda currently works at IRISO Electronics Co., Ltd., as Director, EVP & General Manager-Manufacturing from 2023.
Yoshisada Takeda worked as the Director and Head of Sales & Real Estate at Takenaka Corp..
Mr. Takeda attended Keio University where he received his undergraduate degree in 1972.
Shinobu Takeda served as an Independent Outside Director at Comany, Inc. from 2013 to 2017.
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
Yutaka Takeda has worked as an Auditor at Onamba Co., Ltd.
since 2014.
Toru Takeda currently works at TV Asahi Corp.
(New), as Vice Chairman from 2019 and TV Asahi Holdings Corp., as Director from 2019.
Aucun résultat pour cette recherche
- Bourse
- Recherche avancée
- Norimasa Takeda